Concepedia

Jillian DiMuzio

JD

24

Publications

1.7K

Citations

19

H-Index

1992

Active since

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

IRBM Science Park

Jillian DiMuzio is an author at United States Military Academy specializing in medicine, drug discovery, and pharmacology.

Top concepts

MedicineDrug DiscoveryNatural SciencesPharmacologyBiochemistryMolecular BiologyHepatitisViral HepatitisMedicinal ChemistryImmunology

Publications per year

1992–2021

24

Publications

24

MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants

Vincenzo Summa, Steven W. Ludmerer, John A. McCauley et al. · Antimicrobial Agents and Chemotherapy · 2012 · 254 citations · Full text

Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor

Steven J. Harper, John A. McCauley, Michael T. Rudd et al. · ACS Medicinal Chemistry Letters · 2012 · 201 citations · Full text

Immunology, Molecular Biology, Pharmacotherapy +19

Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor

John A. McCauley, Charles McIntyre, Michael T. Rudd et al. · Journal of Medicinal Chemistry · 2010 · 176 citations

Immunology, Antiviral Drug, Medicinal Chemistry +17

MK-7009, a Potent and Selective Inhibitor of Hepatitis C Virus NS3/4A Protease

Nigel J. Liverton, Steven S. Carroll, Jillian DiMuzio et al. · Antimicrobial Agents and Chemotherapy · 2009 · 141 citations · Full text

Immunology, Molecular Biology, Antiviral Drug +17

Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils

Donald G. Raible, Edward S. Schulman, Jillian DiMuzio et al. · The Journal of Immunology · 1992 · 135 citations

Rows per page

1–5 of 24